Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
Sobha SivaprasadLaser and Retinal Research Unit, King’s College Hospital, UKAbstract: Age-related macular degeneration (AMD) is responsible for more than half the blind registration in the United Kingdom. Retinal manifestations of AMD can be categorized as either atrophic or neovascula...
Guardado en:
Autor principal: | Sobha Sivaprasad |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e50ab6501f274d3192e46e87d9713aef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
por: Sobha Sivaprasad, et al.
Publicado: (2008) -
Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany
por: Nikolaus Feucht, et al.
Publicado: (2008) -
Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases
por: Roopa Vemala, et al.
Publicado: (2010) -
Treatment of neovascular age-related macular degeneration in patients with diabetes
por: Michael Cummings, et al.
Publicado: (2008) -
Treatment of neovascular age-related macular degeneration: Current therapies
por: Albert J Augustin, et al.
Publicado: (2009)